By Sahil Pandey April 21 (Reuters) - Quest Diagnostics on Tuesday raised its forecast for 2026 profit and revenue after posting first-quarter results above Wall Street estimates, citing resilient ...

April 21 (Reuters) - Quest Diagnostics on Tuesday raised its forecast for 2026 profit and revenue after posting first-quarter results above Wall Street estimates, citing resilient demand for routine ...

Quest Diagnostics plans to acquire Canada-based community laboratory provider LifeLabs in a deal worth nearly $1 billion. Under the agreement announced July 3, the Secaucus-headquartered testing ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics is rated a Buy driven by demographic tailwinds, improving reimbursement, and disciplined capital returns.

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...

During the Martha’s Vineyard African-American Film Festival August 5 to 13, Quest Diagnostics offered participants COVID-19 testing on the popular Massachusetts island off the coast of Cape Cod.

Starting today, people in the US can order the tests on Quest's consumer testing site without visiting a doctor. At $119, the kit is one of the more expensive offered on Quest's site. It requires a ...

But even Labcorp and Quest have limits to how many test machines they can afford. As publicly traded companies that must return profits to shareholders, they can’t invest tens of millions of dollars ...